Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16


Prior exposure to salient win-paired cues in a rat gambling task increases sensitivity to cocaine self-administration and suppresses dopamine efflux in nucleus accumbens: support for the reward deficiency hypothesis of addiction.

Ferland JN, Hynes TJ, Hounjet CD, Lindenbach D, Vonder Haar C, Adams WK, Phillips AG, Winstanley CA.

J Neurosci. 2019 Jan 9. pii: 3477-17. doi: 10.1523/JNEUROSCI.3477-17.2018. [Epub ahead of print]


Activation of the ventral subiculum reinvigorates behavior after failure to achieve a goal: Implications for dopaminergic modulation of motivational processes.

Lindenbach D, Seamans JK, Phillips AG.

Behav Brain Res. 2019 Jan 1;356:266-270. doi: 10.1016/j.bbr.2018.09.002. Epub 2018 Sep 7.


D-512, a novel dopamine D2/3 receptor agonist, demonstrates greater anti-Parkinsonian efficacy than ropinirole in Parkinsonian rats.

Lindenbach D, Das B, Conti MM, Meadows SM, Dutta AK, Bishop C.

Br J Pharmacol. 2017 Sep;174(18):3058-3071. doi: 10.1111/bph.13937. Epub 2017 Aug 11.


The Role of Primary Motor Cortex (M1) Glutamate and GABA Signaling in l-DOPA-Induced Dyskinesia in Parkinsonian Rats.

Lindenbach D, Conti MM, Ostock CY, George JA, Goldenberg AA, Melikhov-Sosin M, Nuss EE, Bishop C.

J Neurosci. 2016 Sep 21;36(38):9873-87. doi: 10.1523/JNEUROSCI.1318-16.2016.


Monoamine transporter contributions to l-DOPA effects in hemi-parkinsonian rats.

Conti MM, Meadows SM, Melikhov-Sosin M, Lindenbach D, Hallmark J, Werner DF, Bishop C.

Neuropharmacology. 2016 Nov;110(Pt A):125-134. doi: 10.1016/j.neuropharm.2016.07.025. Epub 2016 Jul 21.


Effect of tricyclic antidepressants on L-DOPA-induced dyskinesia and motor improvement in hemi-parkinsonian rats.

Conti MM, Goldenberg AA, Kuberka A, Mohamed M, Eissa S, Lindenbach D, Bishop C.

Pharmacol Biochem Behav. 2016 Mar;142:64-71. doi: 10.1016/j.pbb.2016.01.004. Epub 2016 Jan 11.


Alterations in primary motor cortex neurotransmission and gene expression in hemi-parkinsonian rats with drug-induced dyskinesia.

Lindenbach D, Conti MM, Ostock CY, Dupre KB, Bishop C.

Neuroscience. 2015 Dec 3;310:12-26. doi: 10.1016/j.neuroscience.2015.09.018. Epub 2015 Sep 9.


Effects of the beta-adrenergic receptor antagonist Propranolol on dyskinesia and L-DOPA-induced striatal DA efflux in the hemi-parkinsonian rat.

Bhide N, Lindenbach D, Barnum CJ, George JA, Surrena MA, Bishop C.

J Neurochem. 2015 Jul;134(2):222-32. doi: 10.1111/jnc.13125. Epub 2015 Apr 27.


Side effect profile of 5-HT treatments for Parkinson's disease and L-DOPA-induced dyskinesia in rats.

Lindenbach D, Palumbo N, Ostock CY, Vilceus N, Conti MM, Bishop C.

Br J Pharmacol. 2015 Jan;172(1):119-30. doi: 10.1111/bph.12894. Epub 2014 Nov 24.


Effects of noradrenergic denervation by anti-DBH-saporin on behavioral responsivity to L-DOPA in the hemi-parkinsonian rat.

Ostock CY, Lindenbach D, Goldenberg AA, Kampton E, Bishop C.

Behav Brain Res. 2014 Aug 15;270:75-85. doi: 10.1016/j.bbr.2014.05.009. Epub 2014 May 13.


Critical involvement of the motor cortex in the pathophysiology and treatment of Parkinson's disease.

Lindenbach D, Bishop C.

Neurosci Biobehav Rev. 2013 Dec;37(10 Pt 2):2737-50. doi: 10.1016/j.neubiorev.2013.09.008. Epub 2013 Oct 7. Review.


Effects of prolonged selective serotonin reuptake inhibition on the development and expression of L-DOPA-induced dyskinesia in hemi-parkinsonian rats.

Conti MM, Ostock CY, Lindenbach D, Goldenberg AA, Kampton E, Dell'isola R, Katzman AC, Bishop C.

Neuropharmacology. 2014 Feb;77:1-8. doi: 10.1016/j.neuropharm.2013.09.017. Epub 2013 Sep 22.


Effects of 5-HT1A receptor stimulation on striatal and cortical M1 pERK induction by L-DOPA and a D1 receptor agonist in a rat model of Parkinson's disease.

Lindenbach D, Dupre KB, Eskow Jaunarajs KL, Ostock CY, Goldenberg AA, Bishop C.

Brain Res. 2013 Nov 6;1537:327-39. doi: 10.1016/j.brainres.2013.09.020. Epub 2013 Sep 21.


The effects of BMY-14802 against L-DOPA- and dopamine agonist-induced dyskinesia in the hemiparkinsonian rat.

Bhide N, Lindenbach D, Surrena MA, Goldenberg AA, Bishop C, Berger SP, Paquette MA.

Psychopharmacology (Berl). 2013 Jun;227(3):533-44. doi: 10.1007/s00213-013-3001-4. Epub 2013 Feb 7.


Effects of noradrenergic denervation on L-DOPA-induced dyskinesia and its treatment by α- and β-adrenergic receptor antagonists in hemiparkinsonian rats.

Barnum CJ, Bhide N, Lindenbach D, Surrena MA, Goldenberg AA, Tignor S, Klioueva A, Walters H, Bishop C.

Pharmacol Biochem Behav. 2012 Jan;100(3):607-15. doi: 10.1016/j.pbb.2011.09.009. Epub 2011 Sep 25.


Behavioral and cellular modulation of L-DOPA-induced dyskinesia by beta-adrenoceptor blockade in the 6-hydroxydopamine-lesioned rat.

Lindenbach D, Ostock CY, Eskow Jaunarajs KL, Dupre KB, Barnum CJ, Bhide N, Bishop C.

J Pharmacol Exp Ther. 2011 Jun;337(3):755-65. doi: 10.1124/jpet.111.179416. Epub 2011 Mar 14.

Supplemental Content

Loading ...
Support Center